Professionals | Aplastic Anemia & MDS International Foundation Return to top.


Introductory image: Patients at the Las Vegas conference

Great Debates & Updates in Hematologic Malignancies is a multi-day, debate driven conference focusing on the treatment of blood cancer. The unique agenda provides opportunities to hear both sides of a current or controversial topic, allowing attendees to form well-rounded opinions based on the comprehensive research and analysis. Hewmatolohisys, medical oncologists, physicians, physician assiatants, physicians-in-training, oncology nurses, and pharmacists are encouraged to attend. The 2023 Great Debates & Updates in Hematologic Malignancies series will take place on:

  • April 13-15, 2023 – New York, NY
  • June 21-23, 2023 – Virtual Event
  • August 17-19, 2023 – Boston, MA

For more information about the event, visit



A Thread to Pull: Unraveling the Complexities of Myeloid Malignancies - View On Demand

CE Accreditation Period:  1/16/2023 – 1/16/2025
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)
Presenter: Sudipto Mukherjee, MD, MPH
Presenter: Bhumika Patel, MD
Presenter: Rodrigo Calado, MD, PhD
Presenter: Guillermo Sanz, MD, PhD
Presenter: Roland B. Walter, MD, PhD, MS
Presenter: Gabriela Hobbs, MD
Presenter: Craig S. Sauter, MD

This complimentary CME satellite symposium provides an in-depth and up-to-date review of research related to biology, prognosis, natural history, and therapeutic management of patients with myeloid malignancies including PNH, MDS, AML, MPN and related myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.
Register here to watch on-demand.


Providing Equitable and Inclusive Care to Patients with Bone Marrow Failure Conditions  

This free virtual symposium provides updates on the most recent advances in the pathophysiology, diagnosis and clinical management of bone marrow failure diseases, including aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), secondary acute myeloid leukemia (AML) and hematopoietic stem cell transplantation. Additionally, the program addresses the current gaps in patient care for each of these diseases, such as clinical trial enrollment, reaching diverse patient populations, barriers to care, diagnostic challenges, genetic profiling, long term supportive care, and quality of life issues. Speakers include representatives of innovative programs focusing on closing inequities and underserved patient populations. The patient voice is also represented through patient panelists and patient survey responses. 

Target Audience:  Physicians, Fellows, APPs, NPs, nurses and social workers.  

Program Sessions:

                               - Low-Risk MDS – Namrata Chandhok, MD, Assistant Professor,
                                 Sylvester Comprehensive Cancer Center, University of Miami 
                               - High-Risk MDS – Mikkael Sekeres, MD, MS
                                 Professor, Sylvester Comprehensive Cancer Center, University of Miami 

                               - Addressing the Gaps in Serving Patients with MDS - Panel Discussion             
                                 Irum Khan, MD, MS, Associate Professor, University of Illinois
                                 Leyla Shune, MD, Associate Professor, Hematologic Malignancies and Cellular
                                 Therapeutics University of Kansas Cancer Center

                               Carlos DeCastro, MD, Professor, Duke University

                             - Addressing the Gaps in Serving Patients with Aplastic Anemia and PNH - Panel
                               Emma Groarke, MD, NHLBI Hematology Branch
                               Susie Lee, PA-C, Keck School of Medicine, University of Southern California
                               Debra O’Neal, MSW, Patient

                             Amy DeZern, MD, MPH – Johns Hopkins University 

                           - Addressing the Gaps in Serving Transplant Patients - Panel Discussion
                             Linda Burns, MD, Consultant and Senior Scientific Director, National Marrow Donor
                             Program, CIBMTR
                             Nandita Khera, MD, MPH, Associate Professor, Mayo Clinic Arizona

                            Jennifer Lotter PA, NHLBI Hematology Branch
                            Sandrine Niyongere, MD, Assistant Professor, University of Maryland 
                            Anastasia Marie Santiago, DNP, APRN, FNP-BC, AOCNP, Sylvester Comprehensive
                            Cancer Center, University of Miami Hospital and Clinics

Watch the full Symposium HERE


Leukemia, Lymphoma & Myeloma Congress

October 18-21, 2023
New York City, NY

Registration and Information HERE


Bone Marrow Failure Disease Scientific Symposium 2022

This biennial Scientific Symposium is the only international forum focused solely on bone marrow failure diseases. The world’s leading researchers on aplastic anemia, MDS, and PNH convened to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field. 

Symposium Co-Chairs:  Richard Stone, MD, Dana-Farber Cancer Institute and Neal Young, MD, NHLBI

Symposium sessions included:

Thursday, May 19
• Genetics and Genomics of Bone Marrow Failure
• Somatic Mutations in Benign Diseases:  AA, PNH, VEXAS Syndrome
• Advances in Paroxysmal Nocturnal Hemoglobinuria
• Transplantation for Bone Marrow Failure
• Non-transplant Therapies for Marrow Failure

Friday, May 20
• MDS and Secondary AML Pathophysiology
• MDS Tools for Prognosis:  Regaining Consensus
• Treatments for MDS and Secondary AML

View session leaders’ summary interviews here

The symposium is supported by educational grants from Novartis, Alexion, Apellis, Biocryst, Regeneron, and Geron.


Share with